Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis

Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Concentra Group Holdings Parent, Inc.
Concentra Group Holdings Parent, Inc. News
Concentra Group Holdings Parent, Inc. Quantitative Score

About Concentra Group Holdings Parent, Inc.
Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. operates as a subsidiary of Select Medical Corporation.
Concentra Group Holdings Parent, Inc. Earnings & Revenue
Concentra Group Holdings Parent, Inc. Financials
Table Compare
Compare CON metrics with: | |||
---|---|---|---|
Earnings & Growth | CON | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | CON | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | CON | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | CON | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Concentra Group Holdings Parent, Inc. Income
Concentra Group Holdings Parent, Inc. Balance Sheet
Concentra Group Holdings Parent, Inc. Cash Flow
Concentra Group Holdings Parent, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
Metrics | Score |
---|---|
Discounted Cash Flows | Buy |
Return on Equity | Strong Buy |
Return on Assets | Strong Buy |
Debt/Equity Ratio | Strong Sell |
Price/Earnings Ratio | Sell |
Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Concentra Group Holdings Parent, Inc. Dividends
Yield (TTM) | Dividend (TTM) | |
---|---|---|
Infinity% | 0.1875 |
Payment Date | Dividend | Frequency |
---|---|---|
2025-05-29 | 0.0625 | Quarterly |
2025-04-01 | 0.0625 | Quarterly |
2024-11-22 | 0.0625 | Quarterly |
Concentra Group Holdings Parent, Inc. Valuation
Project future cash flows and get the intrinsic value per share.
Historical Market Cap
Shares Outstanding
Concentra Group Holdings Parent, Inc. Executives
Name | Role |
---|---|
Mr. Matthew T. DiCanio M.B.A., MBA | President & Chief Financial Officer |
Mr. William Keith Newton | Chief Executive Officer & Director |
Mr. John A. deLorimier | Executive Vice President and Chief Information & Technology Officer |
Dr. John R. Anderson DO, FACOEM | Executive Vice President & Chief Medical Officer |
Mr. Giovanni Gallara | Executive Vice President & Chief Clinical Services Officer |
Name | Role | Gender | Date of Birth | Pay |
---|---|---|---|---|
Mr. Matthew T. DiCanio M.B.A., MBA | President & Chief Financial Officer | Male | 1983 | 2.4M |
Mr. William Keith Newton | Chief Executive Officer & Director | Male | 1963 | 1.88M |
Mr. John A. deLorimier | Executive Vice President and Chief Information & Technology Officer | Male | 1960 | 1.43M |
Dr. John R. Anderson DO, FACOEM | Executive Vice President & Chief Medical Officer | 1950 | 1.43M | |
Mr. Giovanni Gallara | Executive Vice President & Chief Clinical Services Officer | Male | 1975 | 1.38M |
Concentra Group Holdings Parent, Inc. Insider Trades
Date | 3 Mar |
Name | ORTENZIO ROBERT A |
Role | Director |
Transaction | Disposed |
Type | J-Other |
Shares | 3070367 |
Date | 3 Mar |
Name | ORTENZIO ROBERT A |
Role | Director |
Transaction | Acquired |
Type | J-Other |
Shares | 1023455 |
Date | 26 Nov |
Name | McAndrew Douglas R. |
Role | See Remarks |
Transaction | Acquired |
Type | A-Award |
Shares | 60000 |
Date | 26 Nov |
Name | Kosuth Michael A. |
Role | See Remarks |
Transaction | Acquired |
Type | A-Award |
Shares | 60000 |
Date | 26 Nov |
Name | Rhine Michael D. |
Role | See Remarks |
Transaction | Acquired |
Type | A-Award |
Shares | 40000 |
Date | Name | Role | Transaction | Type | Shares |
---|---|---|---|---|---|
3 Mar | ORTENZIO ROBERT A | Director | Disposed | J-Other | 3070367 |
3 Mar | ORTENZIO ROBERT A | Director | Acquired | J-Other | 1023455 |
26 Nov | McAndrew Douglas R. | See Remarks | Acquired | A-Award | 60000 |
26 Nov | Kosuth Michael A. | See Remarks | Acquired | A-Award | 60000 |
26 Nov | Rhine Michael D. | See Remarks | Acquired | A-Award | 40000 |